Seventure Partners

MaaT bags €18M to test microbiome modulators in cancer patients

The financing equips MaaT to wrap up a phase 2 trial of its lead microbiome therapy in graft-versus-host disease while expanding into solid tumors.

Nick Paul Taylor Feb 5, 2020 8:26am

Seventure holds first close of €200M microbiome fund

Mar 5, 2019 9:04am

FIRE1 raises $50M to develop remote heart monitoring device

Jan 30, 2018 7:39am

Eligo raises $20M to take CRISPR drug into clinic

Sep 26, 2017 3:00am